These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25921663)

  • 21. Management of HCC.
    de Lope CR; Tremosini S; Forner A; Reig M; Bruix J
    J Hepatol; 2012; 56 Suppl 1():S75-87. PubMed ID: 22300468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current approach to down-staging of hepatocellular carcinoma prior to liver transplantation.
    Hanje AJ; Yao FY
    Curr Opin Organ Transplant; 2008 Jun; 13(3):234-40. PubMed ID: 18685309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Locoregional Therapies in Patients With Hepatocellular Cancer Awaiting Liver Transplantation.
    Thuluvath PJ; To C; Amjad W
    Am J Gastroenterol; 2021 Jan; 116(1):57-67. PubMed ID: 33110015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical decision-making by gastroenterologists and hepatologists for patients with early hepatocellular carcinoma.
    Nathan H; Herlong HF; Gurakar A; Li Z; Koteish AA; Bridges JF; Pawlik TM
    Ann Surg Oncol; 2014 Jun; 21(6):1844-51. PubMed ID: 24522993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of hepatocellular carcinoma.
    Giuliani F; Colucci G
    Oncology; 2009; 77 Suppl 1():43-9. PubMed ID: 20130431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretransplant treatments for hepatocellular carcinoma: do they improve outcomes?
    Di Bisceglie AM
    Liver Transpl; 2005 Nov; (11 Suppl 2):S10-3. PubMed ID: 16237728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sub-classification of intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinomas.
    Yamakado K; Hirota S
    World J Gastroenterol; 2015 Oct; 21(37):10604-8. PubMed ID: 26457020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multimodality treatment involving radiotherapy for advanced liver-confined hepatocellular carcinoma.
    Yoon HI; Seong J
    Oncology; 2014; 87 Suppl 1():90-8. PubMed ID: 25427739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How we approach it: treatment options for hepatocellular carcinoma.
    Hernaez R; El-Serag HB
    Am J Gastroenterol; 2018 Jun; 113(6):791-794. PubMed ID: 29713029
    [No Abstract]   [Full Text] [Related]  

  • 30. Staging for hepatocellular carcinoma: complex and confusing.
    Sherman M
    Gastroenterology; 2014 Jun; 146(7):1599-602. PubMed ID: 24780213
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    Cho YK; Chung JW; Kim JK; Ahn YS; Kim MY; Park YO; Kim WT; Byun JH
    Cancer; 2008 Jan; 112(2):352-61. PubMed ID: 18008352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interventional oncology for hepatocellular carcinoma.
    Delicque J; Boulin M; Guiu B; Pelage JP; Escal L; Schembri V; Assenat E; Fohlen A
    Clin Res Hepatol Gastroenterol; 2016 Nov; 40(5):530-537. PubMed ID: 27055387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma.
    Akateh C; Black SM; Conteh L; Miller ED; Noonan A; Elliott E; Pawlik TM; Tsung A; Cloyd JM
    World J Gastroenterol; 2019 Jul; 25(28):3704-3721. PubMed ID: 31391767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular carcinoma.
    Marrero JA; Pelletier S
    Clin Liver Dis; 2006 May; 10(2):339-51, ix. PubMed ID: 16971265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reassessing the boundaries of liver transplantation for hepatocellular carcinoma: Where do we stand with tumor down-staging?
    Yao FY; Fidelman N
    Hepatology; 2016 Mar; 63(3):1014-25. PubMed ID: 26560491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localized and systemic approaches to treating hepatocellular carcinoma.
    Knox JJ; Cleary SP; Dawson LA
    J Clin Oncol; 2015 Jun; 33(16):1835-44. PubMed ID: 25918289
    [No Abstract]   [Full Text] [Related]  

  • 37. Prognostic prediction and treatment strategy in hepatocellular carcinoma.
    Bruix J; Llovet JM
    Hepatology; 2002 Mar; 35(3):519-24. PubMed ID: 11870363
    [No Abstract]   [Full Text] [Related]  

  • 38. LCSGJ-T classification, 6th or 5th edition TNM staging did not independently predict the long-term prognosis of HBV-related hepatocellular carcinoma after radical hepatectomy.
    Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
    J Surg Res; 2010 Mar; 159(1):538-44. PubMed ID: 19111323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonsurgical treatment of hepatocellular carcinoma.
    Llovet JM; Sala M; Bruix J
    Liver Transpl; 2000 Nov; 6(6 Suppl 2):S11-5. PubMed ID: 11084079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment strategies of intermediate-stage hepatocellular carcinomas in Japan (Barcelona Clinic Liver Cancer stage B).
    Yamakado K; Kudo M
    Oncology; 2014; 87 Suppl 1():78-81. PubMed ID: 25427737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.